{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:39Z","timestamp":1792047819781,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7686","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/nature25025","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T14:35:10Z","timestamp":1514903710000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727"],"prefix":"10.1038","volume":"553","author":[{"given":"Nathan","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bottegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Koglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Cansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jazayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"BFnature25025_CR1","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","volume":"48","author":"TM Woodruff","year":"2011","unstructured":"Woodruff, T. M., Nandakumar, K. S. & Tedesco, F. Inhibiting the C5-C5a receptor axis. Mol. Immunol. 48, 1631\u20131642 (2011)","journal-title":"Mol. Immunol."},{"key":"BFnature25025_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1124\/pr.111.005223","volume":"65","author":"A Klos","year":"2013","unstructured":"Klos, A., Wende, E., Wareham, K. J. & Monk, P. N. International Union of Basic and Clinical Pharmacology. Complement peptide C5a, C4a, and C3a receptors. Pharmacol. Rev. 65, 500\u2013543 (2013)","journal-title":"Pharmacol. Rev."},{"key":"BFnature25025_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","volume":"12","author":"C Landlinger","year":"2015","unstructured":"Landlinger, C. et al. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer\u2019s disease. J. Neuroinflammation 12, 150 (2015)","journal-title":"J. Neuroinflammation"},{"key":"BFnature25025_CR4","first-page":"139","volume":"39","author":"AJ Hutchison","year":"2004","unstructured":"Hutchison, A. J. & Krause, J. E. The discovery of small molecule C5a antagonists. Annu. Rep. Med. Chem. 39, 139\u2013147 (2004)","journal-title":"Annu. Rep. Med. Chem."},{"key":"BFnature25025_CR5","doi-asserted-by":"publisher","first-page":"49403","DOI":"10.1074\/jbc.M209672200","volume":"277","author":"H Sumichika","year":"2002","unstructured":"Sumichika, H. et al. Identification of a potent and orally active non-peptide C5a receptor antagonist. J. Biol. Chem. 277, 49403\u201349407 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1124\/jpet.108.141572","volume":"327","author":"RM Brodbeck","year":"2008","unstructured":"Brodbeck, R. M. et al. Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist. J. Pharmacol. Exp. Ther. 327, 898\u2013909 (2008)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature25025_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1073\/pnas.0711253105","volume":"105","author":"MJ Serrano-Vega","year":"2008","unstructured":"Serrano-Vega, M. J., Magnani, F., Shibata, Y. & Tate, C. G. Conformational thermostabilization of the \u03b21-adrenergic receptor in a detergent-resistant form. Proc. Natl Acad. Sci. USA 105, 877\u2013882 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25025_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2010.07.001","volume":"60","author":"N Robertson","year":"2011","unstructured":"Robertson, N. et al. The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 60, 36\u201344 (2011)","journal-title":"Neuropharmacology"},{"key":"BFnature25025_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nature20606","volume":"540","author":"C Oswald","year":"2016","unstructured":"Oswald, C. et al. Intracellular allosteric antagonism of the CCR9 receptor. Nature 540, 462\u2013465 (2016)","journal-title":"Nature"},{"key":"BFnature25025_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11558","volume":"490","author":"JF White","year":"2012","unstructured":"White, J. F. et al. Structure of the agonist-bound neurotensin receptor. Nature 490, 508\u2013513 (2012)","journal-title":"Nature"},{"key":"BFnature25025_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14287","volume":"520","author":"D Zhang","year":"2015","unstructured":"Zhang, D. et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520, 317\u2013321 (2015)","journal-title":"Nature"},{"key":"BFnature25025_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature22309","volume":"545","author":"RKY Cheng","year":"2017","unstructured":"Cheng, R. K. Y. et al. Structural insight into allosteric modulation of protease-activated receptor 2. Nature 545, 112\u2013115 (2017)","journal-title":"Nature"},{"key":"BFnature25025_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature17414","volume":"533","author":"A Jazayeri","year":"2016","unstructured":"Jazayeri, A. et al. Extra-helical binding site of a glucagon receptor antagonist. Nature 533, 274\u2013277 (2016)","journal-title":"Nature"},{"key":"BFnature25025_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nsmb.3417","volume":"24","author":"J Lu","year":"2017","unstructured":"Lu, J. et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Nat. Struct. Mol. Biol. 24, 570\u2013577 (2017)","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnature25025_CR15","doi-asserted-by":"publisher","first-page":"40617","DOI":"10.1074\/jbc.M509245200","volume":"280","author":"SM Waters","year":"2005","unstructured":"Waters, S. M. et al. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction. J. Biol. Chem. 280, 40617\u201340623 (2005)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Crystal structure of the \u03b22 adrenergic receptor\u2013Gs protein complex. Nature 477, 549\u2013555 (2011)","journal-title":"Nature"},{"key":"BFnature25025_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature09648","volume":"469","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the \u03b22 adrenoceptor. Nature 469, 175\u2013180 (2011)","journal-title":"Nature"},{"key":"BFnature25025_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pharmthera.2014.02.004","volume":"143","author":"BG Tehan","year":"2014","unstructured":"Tehan, B. G., Bortolato, A., Blaney, F. E., Weir, M. P. & Mason, J. S. Unifying family A GPCR theories of activation. Pharmacol. Ther. 143, 51\u201360 (2014)","journal-title":"Pharmacol. Ther."},{"key":"BFnature25025_CR19","doi-asserted-by":"publisher","first-page":"35354","DOI":"10.1074\/jbc.M305607200","volume":"278","author":"DH Floyd","year":"2003","unstructured":"Floyd, D. H. et al. C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J. Biol. Chem. 278, 35354\u201335361 (2003)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR20","doi-asserted-by":"publisher","first-page":"35345","DOI":"10.1074\/jbc.M305606200","volume":"278","author":"JM Klco","year":"2003","unstructured":"Klco, J. M., Lassere, T. B. & Baranski, T. J. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem. 278, 35345\u201335353 (2003)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR21","doi-asserted-by":"publisher","first-page":"31038","DOI":"10.1074\/jbc.M805260200","volume":"283","author":"MJ Rabiet","year":"2008","unstructured":"Rabiet, M. J., Huet, E. & Boulay, F. Complement component 5a receptor oligomerization and homologous receptor down-regulation. J. Biol. Chem. 283, 31038\u201331046 (2008)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov, V. et al. High-resolution crystal structure of an engineered human \u03b22-adrenergic G protein-coupled receptor. Science 318, 1258\u20131265 (2007)","journal-title":"Science"},{"key":"BFnature25025_CR23","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.1074\/jbc.271.27.16384","volume":"271","author":"TE Hebert","year":"1996","unstructured":"Hebert, T. E. et al. A peptide derived from a \u03b22-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384\u201316392 (1996)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR24","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066\u20131071 (2010)","journal-title":"Science"},{"key":"BFnature25025_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature10954","volume":"485","author":"A Manglik","year":"2012","unstructured":"Manglik, A. et al. Crystal structure of the \u03bc-opioid receptor bound to a morphinan antagonist. Nature 485, 321\u2013326 (2012)","journal-title":"Nature"},{"key":"BFnature25025_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10939","volume":"485","author":"H Wu","year":"2012","unstructured":"Wu, H. et al. Structure of the human \u03ba-opioid receptor in complex with JDTic. Nature 485, 327\u2013332 (2012)","journal-title":"Nature"},{"key":"BFnature25025_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12167","volume":"497","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Structure of the human smoothened receptor bound to an antitumour agent. Nature 497, 338\u2013343 (2013)","journal-title":"Nature"},{"key":"BFnature25025_CR28","doi-asserted-by":"publisher","first-page":"17831","DOI":"10.1074\/jbc.M410797200","volume":"280","author":"A Higginbottom","year":"2005","unstructured":"Higginbottom, A. et al. Comparative agonist\/antagonist responses in mutant human C5a receptors define the ligand binding site. J. Biol. Chem. 280, 17831\u201317840 (2005)","journal-title":"J. Biol. Chem."},{"key":"BFnature25025_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protocols 4, 706\u2013731 (2009)","journal-title":"Nat. Protocols"},{"key":"BFnature25025_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D 66, 125\u2013132 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D 69, 1204\u20131214 (2013)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR32","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760\u2013763 (1994)"},{"key":"BFnature25025_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D 67, 235\u2013242 (2011)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Crystallogr."},{"key":"BFnature25025_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D 67, 355\u2013367 (2011)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature25025_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296 (2016)","journal-title":"J. Chem. Theory Comput."},{"key":"BFnature25025_CR40","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","volume":"97","author":"GJ Martyna","year":"1992","unstructured":"Martyna, G. J., Klein, M. L. & Tuckerman, M. Nos\u00e9-Hoover chains: the canonical emsemble via continuous dynamics. J. Chem. Phys. 97, 2635\u20132643 (1992)","journal-title":"J. Chem. Phys."},{"key":"BFnature25025_CR41","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G. J., Tobias, D. J. & Klein, M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177\u20134189 (1994)","journal-title":"J. Chem. Phys."},{"key":"BFnature25025_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler, V., van Gunsteren, W. F. & Hunenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501\u2013508 (2001)","journal-title":"J. Comput. Chem."},{"key":"BFnature25025_CR43","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1063\/1.463137","volume":"97","author":"M Tuckerman","year":"1992","unstructured":"Tuckerman, M., Berne, B. J. & Martyna, G. J. Reversible multiple time scale molecular dynamics. J. Chem. Phys. 97, 1990\u20132001 (1992)","journal-title":"J. Chem. Phys."},{"key":"BFnature25025_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338, 27\u201328 (1996)","journal-title":"J. Mol. Graph."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature25025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature25025","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature25025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature25025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:10:12Z","timestamp":1684419012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature25025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"journal-issue":{"issue":"7686","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFnature25025"],"URL":"https:\/\/doi.org\/10.1038\/nature25025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732391665.793542404","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"9 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are employees of Heptares Therapeutics and are shareholders of Sosei Group, the parent company of Heptares. Heptares is a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}